Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Logo MUG-Forschungsportal

Gewählte Publikation:

SHR Neuro Krebs Kardio Lipid

Moazedi-Fuerst, FC; Kielhauser, SM; Hermann, J; Meilinger, M; Demel, U; Stradner, MH; Graninger, WB.
Decrease in autoantibody titres during long-term treatment of scleroderma with rituximab: a promising surveillance marker of therapy?
Scand J Rheumatol. 2015; 44(6):519-520 (- Case Report)
Web of Science PubMed FullText FullText_MUG

 

Autor/innen der Med Uni Graz:
Demel Ulrike
Graninger Winfried
Hermann Josef
Kielhauser Sonja
Meilinger Michael
Moazedi-Fürst Florentine
Stradner Martin Helmut
Altmetrics:

Dimensions Citations:

Plum Analytics:
Find related publications in this database (using NLM MeSH Indexing)
Antibodies, Antinuclear - blood
Antibodies, Antinuclear - immunology
Antirheumatic Agents - therapeutic use
Autoantibodies - blood
Autoantibodies - immunology
Biomarkers - blood
DNA Topoisomerases, Type I - blood
DNA Topoisomerases, Type I - immunology
Dose-Response Relationship, Drug -
Humans -
Immunologic Surveillance -
Rituximab - therapeutic use
Scleroderma, Diffuse - blood
Scleroderma, Diffuse - drug therapy
Scleroderma, Diffuse - immunology
Sensitivity and Specificity -
Time Factors -
Treatment Outcome -

© Meduni Graz Impressum